ATA-200, an experimental gene therapy for children with LGMDR5, has so far been tolerated well in an early clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results